- Home
- CRBU
as 01-21-2025 4:00pm EST
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | BERKELEY |
| Market Cap: | 151.2M | IPO Year: | 2021 |
| Target Price: | $11.80 | AVG Volume (30 days): | 1.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.65 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.50 - $8.33 | Next Earning Date: | 03-10-2025 |
| Revenue: | $11,475,000 | Revenue Growth: | -66.85% |
| Revenue Growth (this year): | -69.64% | Revenue Growth (next year): | -1.18% |
Latest Caribou Biosciences Inc. News
CRBU Breaking Stock News: Dive into CRBU Ticker-Specific Updates for Smart Investing
MT Newswires
9 days ago
Caribou Biosciences Starts Phase 1 Trial for Lupus Drug Candidate
GlobeNewswire
9 days ago
Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025
GlobeNewswire
14 days ago
Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
MT Newswires
15 days ago
BofA Securities Cuts Price Target on Caribou Biosciences to $11 From $13, Maintains Buy Rating
MT Newswires
20 days ago
Caribou Biosciences Names Sri Ryali CFO
GlobeNewswire
20 days ago
Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer
Insider Monkey
22 days ago
Why Is Caribou Biosciences Inc. (CRBU) Among the Top CRISPR Stocks to Invest In?
Simply Wall St.
a month ago
Here's Why Caribou Biosciences (NASDAQ:CRBU) Must Use Its Cash Wisely
Compare CRBU vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CRBU Caribou Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.